Minor Serous and Clear Cell Components Adversely Affect Prognosis in “Mixed-Type” Endometrial Carcinomas: A Clinicopathologic Study of 36 Stage-I Cases
Authors:
- M. Ruhul QuddusMQM. Ruhul Quddus
- C. James SungCSC. James Sung
- Cunxian ZhangCZCunxian Zhang
- W. Dwayne LawrenceWLW. Dwayne Lawrence
- 1 July 2010
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 17 (7) , 673-678
Abstract
Most endometrial carcinomas contain only 1 Müllerian cell type although the presence of 2 or more cell types within 1 tumor, for example a predominantly low-grade endometrioid carcinoma with a minor component (arbitrarily defined as 30% or less) of high-grade serous and/or clear cell carcinoma, is not uncommon. The current study attempts to evaluate whether the presence of minor serous or clear cell components exerts an adverse effect on the prognosis in stage-I endometrial carcinomas of ‘‘mixed-type.’’ The study cases include 22 cases of stage-I endometrioid carcinoma with a minor component of serous carcinoma and 14 cases of endometrioid carcinoma with a minor component of clear cell carcinoma. Minor components were arbitrarily defined as representing anywhere between 5% and 30% of the total tumor. The study cases were compared with 56 cases of histologically pure age-matched and stage-matched endometrioid carcinomas, 6 pure serous carcinomas, and 13 pure clear cell carcinomas. All study and control cases were fully staged. Treatment history and outcome status were obtained and follow-up ranged from 56 to 140 months. Our study suggests that the presence of minor components of serous and clear cell carcinoma, defined as between 5% and 30%, within a mixed-type endometrial carcinoma appears to adversely influence the long-term survival of stage-I tumors, although a larger study is needed to corroborate our findings.Keywords
This publication has 12 references indexed in Scilit:
- Early stage uterine papillary serous carcinoma of the endometriumCancer, 2001
- The Outcome of Stage I–II Clinically and Surgically Staged Papillary Serous and Clear Cell Endometrial Cancers When Compared with Endometrioid CarcinomaGynecologic Oncology, 2000
- Mixed serous—endometrioid carcinoma of the uterus: pathologic and cytopathologic analysis of a high-risk endometrial carcinomaInternational Journal of Gynecological Cancer, 1994
- Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinomaGynecologic Oncology, 1992
- Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic FeaturesAmerican Journal of Surgical Pathology, 1992
- Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total populationInternational Journal of Gynecological Cancer, 1992
- The new International Federation of Gynecology and Obstetrics surgical staging and survival rates in early endometrial carcinomaCancer, 1992
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991
- Serous papillary carcinoma of the endometrium: A histopathological study of 22 casesGynecologic Oncology, 1990
- Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group studyCancer, 1987